Abstract
Valoctocogene roxaparvovec (ROCTAVIAN((TM))) is a gene therapy being developed by BioMarin Pharmaceutical Inc. for the treatment of haemophilia A. In ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
